Matej F.
- Country
- Czechia
- Department
- NA
Research Overview
- Efficacy and Safety of Baxdrostat and Dapagliflozin on Renal and Cardiovascular Outcomes in Chronic Kidney Disease with Hypertension
- Evaluation of COR-1167 Sodium in Patients with Worsening Heart Failure: A Randomized, Placebo-Controlled, Dose-Response Study
- Evaluation of Vicadrostat and Empagliflozin in Simultaneous vs. Staggered Initiation for Chronic Kidney Disease Progression Risk
Data & Insights
Has run more than one trial at 135 of 385 partner sites.
Specializations
Nephrology Focus
The investigator specializes in treating patients with chronic kidney disease (CKD), with particular attention to complications and progressive renal function decline.
- Renal Function Management
- CKD Progression Prevention
- eGFR Monitoring Approaches
Their work encompasses comprehensive renal care strategies and kidney failure prevention protocols.
Cardiovascular Care
The investigator focuses on cardiovascular health in relation to kidney disease, particularly addressing hypertension management in CKD patients.
- Blood Pressure Control
- Cardiovascular Risk Management
- Cardio-Renal Syndrome
Their expertise extends to integrated cardiovascular care approaches for renal patients.
Therapeutic Innovation
The investigator explores novel therapeutic combinations for managing complex cardio-renal conditions, focusing on innovative treatment approaches.
- Combined Therapy Approaches
- Clinical Outcomes Assessment
- Treatment Optimization
Their work involves evaluating therapeutic efficacy in complex patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.